PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The current condition has uncovered some structural weaknesses within the EU’s medicines provide chain in addition to a large dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She recommended that supply chain difficulties be resolved in an EU pharmaceutical strategy anticipated being launched by the